Mergers & Acquisitions - ViroPharma

Filter

Current filters:

ViroPharma

Popular Filters

Shire strengthens position in rare diseases with $4.2 billion buy of ViroPharma

Shire strengthens position in rare diseases with $4.2 billion buy of ViroPharma

11-11-2013

Ireland-based drugmaker Shire saw its share rise 2.2% to £33.16 shortly after markets opened this morning,…

CinryzeFirazyrMergers & AcquisitionsPharmaceuticalRare diseasesShireViroPharma

ViroPharma buys option to acquire Meritage Pharma

28-12-2011

ViroPharma (Nasdaq: VPHM) has entered into an exclusive option to acquire fellow USA based Meritage Pharma,…

BudesonideMergers & AcquisitionsMeritage PharmaPharmaceuticalRare diseasesResearchViroPharma

ViroPharma to acquire DuoCort Pharma for up to $164 million, adding European orphan drug to pipeline

28-10-2011

The USA’s ViroPharma (Nasdaq: VPHM) says it has signed a definitive agreement to acquire DuoCort…

DuoCort PharmaMergers & AcquisitionsPharmaceuticalPlenadrenRare diseasesViroPharma

Company Spotlight

ImmunoGen

ImmunoGen

Back to top